Remote Senior Medical Science Liaison, Rare Diseases

Otsuka America Pharmaceutical Inc.; Cheyenne (WY); Remote; USD 169,000 - 253,000; Full time

Benefits offered by this job

Comprehensive medical

Dental

Vision

401(k) match

Paid holidays

Tuition reimbursement

Paid leave programs

Flexible time off

Job summary

Otsuka America Pharmaceutical Inc. is seeking a Senior Medical Science Liaison (Sr.

MSL), Rare Diseases, to execute national medical strategies and regional medical business plans across the United States in a remote, full-time capacity. You will engage KOLs, investigators, and care teams, collaborate with cross-functional partners, support clinical trials and education programs, and travel up to 70% as needed to support FUS ALS, PKU, and other LCM indications.

Qualifications

• MD/DO/PharmD/PhD in life sciences required
• Minimum 5+ years of relevant experience within pharmaceutical industry Medical Affairs
• Rare disease experience strongly preferred
• Prior experience engaging healthcare professionals and decision-makers

Responsibilities

• Execute national medical strategies and develop regional medical plans
• Engage key scientific and medical stakeholders across Regions and Centers of Excellence
• Contribute clinical and scientific expertise to planning and execution across pre-launch, launch, and post-launch
• Collaborate with Global Medical Strategy, Advocacy, and Commercial partners while maintaining compliance

Skills

Medical affairs experience

KOL engagement

Stakeholder management

Cross-functional collaboration

Education

MD/DO/PharmD/PhD in life sciences

Job description

Otsuka America Pharmaceutical Inc. is seeking a Senior Medical Science Liaison (Sr.

MSL), Rare Diseases, to execute national medical strategies and regional medical business plans across the United States in a remote, full-time capacity. You will engage KOLs, investigators, and care teams, collaborate with cross-functional partners, support clinical trials and education programs, and travel up to 70% as needed to support FUS ALS, PKU, and other LCM indications.